Opening For Research Group Leader positions - Spain

1 post / 0 new
Amar Annamalai
Amar Annamalai's picture
Opening For Research Group Leader positions - Spain

 IBEC is seeking outstanding, highly motivated candidates for new Group Leader position(s) in its Biomaterials, implants and tissue engineering research lines.
The Institute for Bioengineering of Catalonia (IBEC) is a cutting-edge research centre based in Barcelona. IBEC develops interdisciplinary research of excellence, from basic research to medical applications, in the biomedical engineering and nanomedicine fields.
IBEC was founded in 2005 by the Generalitat de Catalunya, the University of Barcelona and the Universitat Politècnica de Catalunya-BarcelonaTech with the mission to develop international high quality interdisciplinary research that, while creating knowledge, contributes to making a better quality of life, improving health and creating wealth. IBEC aims to consolidate a strong international position in the field of Nanomedicine and Bioengineering, as well as to increase the portfolio of technology transfer services available to the industrial sector and to the healthcare system.
IBEC is located within the Barcelona Science Park, with premises of 2.500 square meters, 16 research groups and a team of researchers and support services of 250 people from 20 different countries, with have diverse backgrounds in physics, engineering, computer science, chemistry and other fields. The location of IBEC in the Barcelona Science Park offers a highly stimulating biomedical environment in which the institute can work closely with organisations from the public and private sector.
The novel vision promoted at IBEC is to exploit and connect the multidisciplinariety of the Institute`s groups aligning their complementary capacities through three broad areas of expertise:
• Nanomedicine: nanobiosensing; microfluidics; nanofabrication using soft lithographies and related techniques; beyond-AFM/ST microscopy tools to characterize biological samples (optical, mechanical, electrical behaviour) at the nanoscale; mechanobiology protocols and their translation to clinical purposes; nano-scale characterization of bacterial-host interactions.
• Cell Engineering: biomaterials for regenerative medicine; reprogramming stem cells; control differentiation of stem cells; rapid prototyping for biomaterials; cell-material interaction, microencapsulation for antibacterials and other therapeutic agents.
• Intelligent Healthcare: application of advanced information and communication technologies to healthcare, such as modelling; signaling processing; automatics/control software for robotics; imaging; robotics (mechanics) for minimally invasive surgery.
To this end, our institute, on the basis of the generation of knowledge in bioengineering and nanomedicine, is to focus the continuation of its scientific and technological work around three core application areas:
• Bioengineering for future medicine, with the aim of developing technology that goes beyond the existing paradigm of medical care in hospital to incorporate new areas such as photopharmacology, organs on chips and diagnosis based on the mechanical behaviour of cells and tissues. The future of medicine will mean personalised medicine, hand-held diagnostic platforms, wearable monitoring devices, and other technological advances to make healthcare more effective, cheaper and more convenient.
• Bioengineering for active ageing, with the aim of developing care and technology to meet the needs of an increasingly ageing population. Biomedical engineering can contribute greatly to improving the quality of life of older people.
• Bioengineering for regenerative therapies, with the aim of developing regeneration technology to allow the creation of implants able to bring about the regeneration of damaged tissues or organs and to develop cell therapies.
Expected research focuses could include (but are not limited to)
- Bioactive biomaterials and biointerfaces that simulate the cellular microenvironment at micro and nanoscale.
- Functional Biomaterials and advance manufacturing (3D scaffolds).
- Decellularized tissue scaffolds.
- 3D tissue models for clinical applications (GMP production)
- Synthetic and Biological matrices for tissue engineering and transplant development
Applicants will be expected to develop an independent research group and contribute to one or more of IBEC’s core application areas and be involved in collaborations with clinicians.
IBEC’s Group Leaders are appointed for an initial 5-year period, with the possibility to extend their appointment after scientific evaluation by the International Scientific Committee (ISC) every 4 years. The ISC is composed of renowned international scientists from different bioengineering fields as well as prestigious professionals in key areas such as technology transfer.
Group Leaders are also offered a competitive start-up package and provided with suitable laboratory space, access to IBEC’s cutting-edge facilities and project management support.
To qualify for a Group Leader position, candidates should hold a PhD/MD degree and a proven record of achievements in their research field. Applicants who currently lead their own group in a University or other research organization are welcome to apply.
Desirable competencies and skills are: Leadership; international reputation; critical judgment in the identification and execution of research activities; strategic vision on the future of the research field; proven record in securing significant research funding / budgets / resources; team building and collaboration; excellent communication and networking skills.
Applicants should provide the following:
• Cover letter together with a description of scientific achievements (max. 1 page);
• Brief outline of research interests and a short research plan for the initial 5 year appointment period (max. 4 pages);
• CV;
• List of publications (with 5 most significant publications in bold);
• Contact details of three referees.
Applications should be submitted by e-mail to no later than 11st January 2015